ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 76 filers reported holding ARCUS BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | -100.0% | 12 | -60.0% | 0.00% | – |
Q2 2022 | $1,000 | -97.8% | 30 | -98.4% | 0.00% | -100.0% |
Q2 2020 | $45,000 | 0.0% | 1,883 | -40.5% | 0.00% | 0.0% |
Q1 2020 | $45,000 | +246.2% | 3,167 | +151.1% | 0.00% | +200.0% |
Q4 2019 | $13,000 | -71.7% | 1,261 | -74.5% | 0.00% | -66.7% |
Q3 2019 | $46,000 | +820.0% | 4,939 | +672.9% | 0.00% | – |
Q2 2019 | $5,000 | +25.0% | 639 | +86.8% | 0.00% | – |
Q1 2019 | $4,000 | – | 342 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |